Pressure BioSciences, Inc. (PBIO)
-OTC Markets 0.30 
0.01(3.23%) 12:54PM EDT
| Prev Close: | 0.31 |
|---|
| Open: | 0.31 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 5.00 |
|---|
| Beta: | 0.55 |
|---|
| Next Earnings Date: | 12-Aug-13 |
|---|
| Day's Range: | 0.30 - 0.31 |
|---|
| 52wk Range: | 0.15 - 0.63 |
|---|
| Volume: | 36,234 |
|---|
| Avg Vol (3m): | 28,231 |
|---|
| Market Cap: | 3.43M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.42 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million GoalPR Newswire(Fri, Jun 14)
- PRESSURE BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct FinanciEDGAR Online(Thu, Jun 13)
- Pressure BioSciences Announces Core Technology BreakthroughPR Newswire(Tue, Jun 4)
- Pressure BioSciences, Inc. Retains Merriman Capital as Capital Markets AdvisorThomson Reuters ONE(Wed, May 29)
- Form 10 K for Pressure BioSciences Inc.WILink(Tue, May 28)
- Pressure BioSciences, Inc. to Present at the Marcum MicroCap ConferencePR Newswire(Tue, May 28)
- PRESSURE BIOSCIENCES INC FinancialsEDGAR Online Financials(Sat, May 25)
- Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business UpdatePR Newswire(Thu, May 23)
- Pressure BioSciences, Inc. Reports Strong First Quarter 2013 Financial ResultsMarketwired(Tue, May 21)
- PRESSURE BIOSCIENCES INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, May 20)
- Breakthrough Method for Lipid Analysis in Fecal Material Developed; New Understanding of Diseases/Disorders Related to Gut Function PossiblePR Newswire(Thu, May 16)
- PRESSURE BIOSCIENCES INC Files SEC form 10-K, Annual ReportEDGAR Online(Mon, May 13)
- First Quarter 10Q for Pressure BioSciences Inc.WILink(Wed, Apr 24)
- Galena Pharma: High Hopes For The Sharesat Seeking Alpha(Mon, Apr 8)
- Further Advancements Made in the Development of an Improved Method For Rape Kit Testing Using Pressure BioSciences' Patented Pressure Cycling Technology (PCT)PR Newswire(Thu, Apr 4)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 2.72 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-11)
: | N/A |
|---|
| Quarterly EPS Est
(Sep-11)
: | N/A |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Pressure BioSciences, Inc. engages in the development of pressure cycling technology (PCT) in the United States. Its PCT technology uses instrumentation that cycles pressure between ambient and ultra-high levels at controlled temperatures and spec...
View More